Adverse analytical finding in recent mountain bike stage race

Cycling SA received notification from the UCI (International Cycing Union) of an adverse analytical finding from a sample provided by Barry Warmback on 18 March 2013 at the Absa Cape Epic.

The analytical report confirmed the presence of the steroid, Stanozolol in his sample. Mr. Warmback is therefore provisionally suspended with immediate effect from competing in any event. The SAIDS (South Africa Institute of Drug-free Sport) process will now take its course.

Cycling SA reiterates its zero-tolerance approach to doping in sport and will continue working with the UCI and SAIDS in the promotion of a drug-free sport via its awareness programmes and extensive testing.